Digest Network Come funziona
Network
/
Società
e-
Non verificato

e-therapeutics plc

Di cosa scriviamo

BiotecnologiaManagement/Organizzazione AziendaleMedicina Salute Benessere

6 comunicati stampa

Guarda tutti i comunicati
11/07/2025
Biotecnologia
Medicina Salute Benessere
e-therapeutics sécurise le développement clinique de son candidat GalOmic ETX-312 grâce à des données non cliniques positives
Fonte
e-therapeutics plc
Emittente
GLOBENEWSWIRE
1.00
0
10/07/2025
Biotecnologia
Medicina Salute Benessere
e-therapeutics De-risks Clinical Path for GalOmic Candidate ETX-312 with Positive Non-clinical Data
Fonte
e-therapeutics plc
Emittente
GLOBENEWSWIRE
1.00
0
07/05/2025
Biotecnologia
e-therapeutics Presents New Data Supporting ETX‑312 as a Differentiated and Disease-Modifying Near-Clinic Treatment for MASH
Fonte
e-therapeutics plc
Emittente
GLOBENEWSWIRE
1.00
0
05/02/2025
Biotecnologia
e-therapeutics présentera des données précliniques relatives à l’ETX-148 lors de l’édition 2025 du Congrès annuel de l’EAHAD
Fonte
e-therapeutics plc
Emittente
GLOBENEWSWIRE
1.00
0
05/02/2025
Biotecnologia
e-therapeutics to Present Preclinical Data on ETX-148 at EAHAD 2025
Fonte
e-therapeutics plc
Emittente
GLOBENEWSWIRE
1.00
0
31/10/2024
Biotecnologia
Management/Organizzazione Aziendale
Medicina Salute Benessere
e-therapeutics Announces Business Updates and Interim Results
Fonte
e-therapeutics plc
Emittente
GLOBENEWSWIRE
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0